Open original FDA record ↗Recall record
- FDA identifier
- Z-2398-2012
- Company in FDA record
- Bio-Rad Laboratories
- FDA classification date
- Sep 17, 2012
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Class II
Reason stated in the source
Prolonged exposure of the MONOLISA Anti-HBs EIA Conjugate Diluent component to light may result in elevated Optical Densities (OD) in some samples such that a negative sample could elevate to a grey zone or low positive result.
Source facts
- Action
- The firm, Bio-Rad Laboratories, Inc., sent an "Important Product Information Bio-Rad MONOLISA Anti-HBs EIA Catalog #25220", letter dated 27 July 2012, to their domestic consignees/customers via FedEx. The International subsidiaries will be notified by e-mail. The consignees/customers were informed of the important storage and handling information regarding the MONOLISA Anti-HBs EIA Conjugate Diluent component . The consignees/customers were instructed to follow the storage and handling instructions as stated in the Package Insert, and compare their laboratories practices to the storage and handling instructions stated by Bio-Rad. Customers who have questions can call Bio Rad Technical Support at 1-800-224-6723, option 2, then option 3.
- Initiated
- 2012-07-27
- Root cause
- Packaging
- Terminated
- 2012-12-14
- Distribution
- Worldwide distribution: USA (nationwide) and countries of: Canada, South Africa, and Zimbabwe.
- Recall number
- Z-2398-2012
- Recall status
- Terminated
- CDRH record ID
- 111868
- FDA classified
- 2012-09-17
- Recall event number
- 62850